NCT04703920 |
Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer |
NCT05922930 |
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer |
NCT05394259 |
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer |
NCT04930783 |
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma |
NCT04117087 |
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer |
NCT05034536 |
Pembrolizumab + Infliximab for Metastatic Melanoma |
NCT05057715 |
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer |
NCT03104439 |
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer |
NCT01638676 |
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients |
NCT04598009 |
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma |
NCT05356117 |
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial |
NCT02870244 |
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes |
NCT03454035 |
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors |
NCT04315233 |
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics |
NCT04024878 |
NeoVax With Nivolumab in Patients With Ovarian Cancer |
NCT04996823 |
Axitinib + Ipilimumab in Advanced Melanoma |
NCT04611568 |
War on Melanoma™ Public Health & Education Campaign |
NCT05373823 |
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors |
NCT05523440 |
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation |
NCT04339140 |
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer |
NCT05827055 |
Proglumide and Chemotherapy for Metastatic Pancreatic Cancer |
NCT05308901 |
Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma |
NCT04971499 |
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma |
NCT05264974 |
Novel RNA-nanoparticle Vaccine for the Treatment of Early Melanoma Recurrence Following Adjuvant Anti-PD-1 Antibody Therapy |
NCT05130177 |
Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma |
NCT03950635 |
Dietary Intervention in Patients With a History of Melanoma |
NCT03311308 |
A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma |
NCT04464759 |
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma |
NCT04570553 |
Use of an Intrauterine Manipulator and Its Correlation With Positive Peritoneal Cytology in Early Stage Endometrial Cancers |
NCT04930991 |
High Dose Omeprazole in Patients With Pancreatic Cancer |
NCT05272462 |
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer |
NCT04020809 |
Neoadjuvant Atezolizumab in Cutaneous Melanoma |
NCT06216938 |
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis |
NCT03842943 |
Neoadjuvant Combination Immunotherapy for Stage III Melanoma |
NCT05089370 |
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma |
NCT05029154 |
Exercise Preconditioning in Ovarian Cancer |
NCT04688658 |
Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma |
NCT04513028 |
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma |
NCT05546827 |
PRISM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma |
NCT04048278 |
Lidocaine Infusion in Pancreatic Cancer |
NCT06250335 |
Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients |
NCT03322995 |
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial |
NCT06194929 |
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma |
NCT05113368 |
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer |
NCT06030622 |
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer |
NCT03957551 |
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma |
NCT05983276 |
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer |
NCT06199986 |
DeADT - Living Well With Prostate Cancer |
NCT05524935 |
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma |
NCT06141031 |
Trial of Radiotherapy in Combination With TTI-101 in Patients With Borderline Resectable Pancreatic Cancer |
NCT05675059 |
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients |
NCT05077280 |
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma |
NCT05836870 |
Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer |
NCT05415917 |
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy |
NCT05764720 |
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach |
NCT05483075 |
Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer |
NCT04318717 |
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma |
NCT05704647 |
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases |
NCT06121180 |
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma |
NCT06036810 |
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy |
NCT05170334 |
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma |
NCT03256201 |
Exercise and Nutrition to Improve Pancreatic Cancer Outcomes |
NCT05360732 |
Redefining FOLFIORINOX in Older Pancreatic Cancer Patients |
NCT05523700 |
Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2) |
NCT04820179 |
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer |
NCT04783467 |
Time Restricted Eating (TRE) Among Endometrial Cancer Patients |
NCT06120972 |
Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency |
NCT04683653 |
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer |
NCT03287271 |
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK |
NCT06199466 |
A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer |
NCT05636111 |
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer |
NCT04473833 |
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer |
NCT05819892 |
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer |
NCT05634525 |
Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients |
NCT04844970 |
Anamorelin Study for Advanced Pancreatic Cancer |
NCT04458402 |
Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer |
NCT05316129 |
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer |
NCT05761951 |
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer |
NCT04386993 |
De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer |
NCT05189457 |
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer |
NCT05467670 |
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer |
NCT05586360 |
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer |
NCT05123807 |
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) |
NCT06295159 |
Biomarker Driven Patient Selection Neoadjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma |
NCT03385486 |
Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors |
NCT03232164 |
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer |
NCT03832361 |
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer |
NCT02672098 |
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer |
NCT03467516 |
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma |
NCT05879913 |
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT |
NCT05926102 |
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) |
NCT05839912 |
Excision of Lymph Node Trial (EXCILYNT) (Mel69) |
NCT05384496 |
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma |
NCT03323944 |
CAR T Cell Immunotherapy for Pancreatic Cancer |
NCT05098210 |
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer |
NCT03769766 |
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance |
NCT03674814 |
Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer |
NCT05779423 |
Cryoablation+Ipilimumab+Nivolumab in Melanoma |
NCT06059118 |
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer |
NCT04346225 |
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer |
NCT05470036 |
Improving Germline Testing in At-Risk Patients With Prostate Cancer |
NCT04700332 |
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer |
NCT05715216 |
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer |
NCT05826470 |
Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging |
NCT04556045 |
Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer |
NCT04633902 |
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation |
NCT06083844 |
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy |
NCT03743298 |
Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma |
NCT05604560 |
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer |
NCT03991130 |
High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma |
NCT05496686 |
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma |
NCT05534646 |
Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer |
NCT04741997 |
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma |
NCT04093323 |
Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma |
NCT05650021 |
Rectal Spacer for Prostate Cancer Radiation Image Guidance |
NCT04562129 |
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients |
NCT05469269 |
Cleveland African American Prostate Cancer Project |
NCT06172283 |
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy |
NCT06047509 |
Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for Guidance |
NCT05004025 |
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma |
NCT03734692 |
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer |
NCT04019964 |
Nivolumab in Biochemically Recurrent dMMR Prostate Cancer |
NCT05668351 |
Stereotactic Ablative Radiation Therapy for Prostate Cancer |
NCT03955978 |
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer |
NCT04665947 |
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer |
NCT05311527 |
UroLift System With SAbR for Prostate Cancer and BPH |
NCT06064149 |
The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study |
NCT06111781 |
The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer |
NCT04981223 |
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging |
NCT05454488 |
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer |
NCT05345444 |
Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) |
NCT04457089 |
Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer |
NCT06014255 |
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer |
NCT05477823 |
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer |
NCT06085729 |
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) |
NCT03223779 |
Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer |
NCT05790213 |
Focal Prostate Ablation With Androgen Deprivation and Novel Hormonal Therapy for Intermediate Risk Prostate Cancer |
NCT05056896 |
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension |
NCT05375539 |
AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients |
NCT05099679 |
Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study |
NCT06171139 |
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer |
NCT04808427 |
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer |
NCT04588025 |
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response |
NCT04842890 |
Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer |
NCT04116775 |
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. |
NCT05761561 |
Trial of Exercise and Lifestyle in Women With Ovarian Cancer |
NCT05942300 |
CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer |
NCT06318273 |
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer |
NCT05959395 |
Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic Tumors |
NCT04552509 |
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer |
NCT04349501 |
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) |
NCT04705038 |
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments |
NCT04167969 |
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer |
NCT03275857 |
Cisplatin in Castration Resistant Prostate Cancer |
NCT03971591 |
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors |
NCT05751941 |
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer |
NCT05679388 |
A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients |
NCT05608694 |
MRI Screening in Men at High Risk of Developing Prostate Cancer |
NCT05068752 |
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer |
NCT05417386 |
FOLFIRINOX + NIS793 in Pancreatic Cancer |
NCT04989946 |
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer |
NCT03585660 |
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy |
NCT02016248 |
Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer |
NCT02705196 |
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer |
NCT05776524 |
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer |
NCT05245006 |
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer |
NCT05628363 |
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer |
NCT03089203 |
CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer |
NCT04402151 |
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer |
NCT05141643 |
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer |
NCT05710380 |
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy |
NCT03753243 |
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer |
NCT05968690 |
Naltrexone and Propranolol Combined With Immunotherapy |
NCT04422132 |
Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks |
NCT03863457 |
[18F] F-GLN by PET/CT in Breast Cancer |
NCT05026983 |
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases |
NCT05011188 |
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer |
NCT05013216 |
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer |
NCT01607008 |
MRI for Assessing Prostate Cancer Response |
NCT02526368 |
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer |
NCT03495427 |
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores |
NCT05304962 |
First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer |
NCT04360330 |
SABER Study for Selected Early Stage Breast Cancer |
NCT05915442 |
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer |
NCT05156905 |
Study of Docetaxel Combined With Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer |
NCT03932409 |
Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer |
NCT05722925 |
Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET |
NCT05851365 |
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer |
NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
NCT05692323 |
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer |
NCT05415696 |
Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy |
NCT02926729 |
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy |
NCT03861975 |
Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening |
NCT04692675 |
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer |
NCT05497778 |
A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer. |
NCT05628883 |
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma |
NCT05504707 |
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer |
NCT04670068 |
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian |
NCT03652428 |
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC) |
NCT05077098 |
Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer |
NCT05913388 |
GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma |
NCT05558956 |
Total Body PET-CT Imaging of Prostate Cancer Using Illuccix |
NCT04502602 |
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer |
NCT06029998 |
Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion |
NCT03765983 |
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases |
NCT02040610 |
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer |
NCT05803941 |
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
NCT05462496 |
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer |
NCT05542407 |
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer |
NCT05074290 |
Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients |
NCT03553602 |
BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy |
NCT05086250 |
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer |
NCT04651452 |
Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors |
NCT04158635 |
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer |
NCT05174286 |
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk |
NCT05014776 |
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer |
NCT05327452 |
Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study |
NCT05613894 |
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT05327465 |
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy |
NCT04754191 |
Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT05051631 |
BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity |
NCT04109729 |
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer |
NCT06129604 |
Pilot Window of Opportunity Trial (POET) |
NCT05978960 |
EXERT-BCN: An Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer |
NCT03543969 |
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma |
NCT05085548 |
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies |
NCT03763838 |
Acupressure for Fatigue in Ovarian Cancer Survivors |
NCT04206319 |
Radium-223 in Biochemically Recurrent Prostate Cancer |
NCT05806814 |
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer |
NCT05331638 |
Prostate Cancer Genius App Education and Home-based PSA Screening for African American Men |
NCT05424783 |
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC) |
NCT05821244 |
Exercise Timing in Breast Cancer Patients |
NCT05743621 |
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer |
NCT04132505 |
Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer |
NCT05931874 |
Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors |
NCT03212170 |
FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer |
NCT05804318 |
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer |
NCT03761706 |
Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging |
NCT04420702 |
Diffusion Basis Spectrum Imaging of the Prostate |
NCT05324098 |
Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy |
NCT05968157 |
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick |
NCT05263492 |
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer |
NCT06229392 |
A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer |
NCT04270149 |
Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer |
NCT06328738 |
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer |
NCT05501548 |
Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer |
NCT06052202 |
A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men |
NCT05378464 |
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer |
NCT02564848 |
Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65 |
NCT06052488 |
Strength After Breast Cancer |
NCT04728633 |
Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases |
NCT04748380 |
Shared Decision-making and Colorectal Cancer Screening |
NCT04465500 |
EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer |
NCT03668431 |
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer |
NCT03742245 |
Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer |
NCT05999812 |
Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer |
NCT05810025 |
FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments |
NCT05950945 |
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer |
NCT02207465 |
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer |
NCT03694756 |
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer |
NCT05343013 |
TAS-102 in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy |
NCT06252545 |
Promoting CT Engagement for Pancreatic Cancer With App |
NCT06151847 |
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma |
NCT05723107 |
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT04336397 |
Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People |
NCT06133348 |
Promoting Resilience in Women With Breast Cancer |
NCT06001268 |
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) |
NCT03321188 |
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients |
NCT06085664 |
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy |
NCT04192071 |
Virtual Human Delivered Nutrition Module for Colorectal Cancer Prevention |
NCT06056830 |
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy |
NCT04768426 |
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer |
NCT05361798 |
T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy |
NCT04039230 |
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. |
NCT04997096 |
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy |
NCT05092763 |
Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer |
NCT05607095 |
Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Metastatic Uveal Melanoma |
NCT05464667 |
Preoperative Irradiation for Stage I Breast Cancer |
NCT04965064 |
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling |
NCT05113485 |
UCLA Breast Cancer Survivor Health Promotion Research Study |
NCT05755984 |
3D Printed Breast Models in the Surgical Management of Breast Cancer |
NCT06081127 |
Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function |
NCT06090916 |
Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer |
NCT03312972 |
Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy |
NCT03496805 |
Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy |
NCT05334732 |
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters) |
NCT06121453 |
Adherence Intervention in Patients With Metastatic Breast Cancer |
NCT05766891 |
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery |
NCT05036226 |
COAST Therapy in Advanced Solid Tumors and Prostate Cancer |
NCT05625659 |
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts |
NCT05483283 |
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care |
NCT05623488 |
CAR T Cells in Mesothelin-Expressing Breast Cancer |
NCT05659797 |
FES BPET-DBT in Newly Diagnosed Breast Cancer |
NCT05895279 |
Assessment of Research Digest Impact for Minority With Prostate Cancer, MiCAP Phase III Study |
NCT04013568 |
Exercise Post-Diagnosis of Breast Cancer |
NCT04914663 |
All-extremity Exercise During Breast Cancer Chemotherapy |
NCT03643861 |
RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI) |
NCT05609435 |
Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer |
NCT05984888 |
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer |
NCT03933670 |
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance |
NCT05704842 |
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy |
NCT05665660 |
Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening |
NCT05130840 |
Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer |
NCT05854498 |
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer |
NCT03025035 |
Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer |
NCT05615753 |
Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors |
NCT06127979 |
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery |
NCT04756765 |
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer |
NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Breast Cancer |
NCT05417451 |
Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors |
NCT06016504 |
Adaptive Virtual Consultation Tool to Enhance Education and Understanding in Patients With Prostate Cancer |
NCT05675579 |
A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC) |
NCT05856773 |
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy |
NCT04141995 |
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer |
NCT03272334 |
Her2-BATS and Pembrolizumab in Metastatic Breast Cancer |
NCT05636943 |
Couples' QOL in Metastatic Breast Cancer |
NCT05633979 |
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer |
NCT06085742 |
BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer |
NCT04508764 |
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome |
NCT04493034 |
Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer |
NCT04594473 |
A Comprehensive Oncology Rehabilitation and Exercise (CORE) Program Among Breast Cancer Survivors |
NCT05384535 |
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort |
NCT06200259 |
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement |
NCT06149481 |
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) |
NCT05957042 |
Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI). |
NCT04633252 |
M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancer |
NCT03400215 |
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer |
NCT05754580 |
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer |
NCT03820141 |
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer |
NCT04858009 |
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis |
NCT05042687 |
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer |
NCT04495257 |
A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC) |
NCT04040569 |
A Phase I Dose Escalation Study of Single Fraction Ablative Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer |
NCT03822494 |
CyberKnife Dose Escalation Prostate Cancer Trial |
NCT05259410 |
Time Restricted Eating During Chemotherapy for Breast Cancer |
NCT05243641 |
Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test |
NCT04354675 |
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer |
NCT06250751 |
Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca |
NCT05933395 |
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor |
NCT05985954 |
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy |
NCT03712813 |
Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors |
NCT05067777 |
Massage for Prostate Cancer-Related Fatigue, mPROSTATE Study |
NCT05160597 |
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy |
NCT04805333 |
Phase 1 Dose Escalation of ArtemiCoffee |
NCT04796220 |
Focused Ultrasound and Gemcitabine in Breast Cancer |
NCT02958774 |
Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation |
NCT05528133 |
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer |
NCT03802851 |
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer |
NCT06027268 |
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer |
NCT06100874 |
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After progrEssion on ENhertu (SATEEN) |
NCT03699995 |
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma |
NCT05219500 |
Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST). |
NCT02706561 |
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery |
NCT01035112 |
Magnetic Resonance Imaging of Breast Cancer |
NCT04990921 |
Study of Palliative Radiation Combined With Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer |
NCT03824145 |
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer |
NCT05716516 |
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) |
NCT05045066 |
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients |
NCT03808077 |
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer |
NCT04243616 |
Cemiplimab in High Risk or Locally Advanced Hormone Receptor Positive HER2 Negative or Triple-Negative Breast Cancer |
NCT05445609 |
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer |
NCT03436745 |
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females |
NCT05305924 |
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer |
NCT05959291 |
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer |
NCT04857502 |
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer |
NCT04523857 |
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer |
NCT04891068 |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
NCT06173362 |
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer |
NCT04427527 |
Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia |
NCT02807597 |
Real-time Intraoperative Breast Cancer Visualization for Margin Assessment |
NCT03492671 |
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer |
NCT04020575 |
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) |
NCT01913106 |
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer |
NCT05169957 |
Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) |
NCT05155033 |
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma |
NCT05588453 |
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain |
NCT05748834 |
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer |
NCT04763174 |
An mHealth Symptom Management Intervention for Colorectal Cancer Patients (mCOPE) |
NCT04709276 |
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer |
NCT04332588 |
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI |
NCT02732171 |
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer |
NCT04968964 |
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing |
NCT05764395 |
Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors |
NCT06019988 |
Effect of Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer |
NCT06257758 |
A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors |
NCT04748042 |
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) |
NCT05176756 |
RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) |
NCT04853043 |
Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer |
NCT04427293 |
Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC) |
NCT05081193 |
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer |
NCT05187832 |
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer |
NCT04450706 |
Functional Precision Oncology for Metastatic Breast Cancer |
NCT05351424 |
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc |
NCT05071937 |
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer |
NCT04273555 |
Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging |
NCT04941430 |
7T MRI Scan for the Early Detection of Melanoma Brain Metastases |
NCT04364672 |
Molecular Neuroimaging to Assess the Link Between Neuroinflammation and Cognitive Impairment in Breast Cancer |
NCT04846478 |
Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC |
NCT05766371 |
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer |
NCT05479578 |
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer |
NCT04090528 |
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer |
NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
NCT06060587 |
Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone |
NCT05478239 |
ArtemiCoffee in Patients With Rising PSA |
NCT06239467 |
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer |
NCT04568616 |
Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) |
NCT04542135 |
Sulindac and Breast Density in Women at Risk of Developing Breast Cancer |
NCT05805371 |
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer |
NCT02935205 |
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer |
NCT05318469 |
Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer |
NCT04698564 |
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging |
NCT03043794 |
Study of Stereotactic Radiotherapy for Breast Cancer |
NCT06026657 |
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer |
NCT05010200 |
The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting. |
NCT05838716 |
High-Dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients |
NCT05765214 |
Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes |
NCT04573231 |
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer |
NCT03861676 |
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT |
NCT05530655 |
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer |
NCT03821246 |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy |
NCT05225363 |
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer |
NCT04725903 |
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer |
NCT05233800 |
mHealth for Breast Cancer Survivors With Insomnia |
NCT03711890 |
Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer |
NCT05101564 |
Umbrella Trial Testing Integrative Subtype-Targeted Therapeutics in HR+ /HER2-Negative Breast Cancer |
NCT05700396 |
Breast Cancer Survivor Educational Intervention |
NCT04965688 |
Systems Biology Guided Therapy for Breast Cancer Positive for Oestrogen Receptor After Aromatase Inhibitor and CDK Inhibition |
NCT04337580 |
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer |
NCT06228768 |
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer |
NCT03801369 |
Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer |
NCT05591131 |
Genetic Testing in African Americans |
NCT05864196 |
Two Fraction Prostate SBRT With DIL SIB |
NCT02070705 |
DCE MRI in Patients With Pancreatic Cancer |
NCT05806138 |
A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction |
NCT05374915 |
Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC) |
NCT05077137 |
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy |
NCT05014295 |
Patient Recall of Cancer Screening and Diagnosis |
NCT05984602 |
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer |
NCT06132087 |
PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy |
NCT05139368 |
Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer |
NCT05676255 |
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project |
NCT06136884 |
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors |
NCT05472792 |
Comparison of Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN) |
NCT04753359 |
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer |
NCT05746897 |
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors |
NCT06129422 |
Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer |
NCT05722327 |
Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer |
NCT04539808 |
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer |
NCT05852041 |
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance |
NCT04645680 |
Effect of Diet on the Immune System in Patients With Stage III-IV Melanoma Receiving Immunotherapy, DIET Study |
NCT06244004 |
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial |
NCT03835819 |
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) |
NCT03889795 |
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors |
NCT05574686 |
Telemonitoring Hypertension and Breast Cancer |
NCT05576896 |
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory |
NCT05867667 |
Cardiac Rehabilitation to Improve Breast Cancer Outcomes |
NCT04458532 |
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer |
NCT06274034 |
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors |
NCT04594187 |
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma |
NCT06323291 |
Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study |
NCT04074720 |
Prospective Breast Cancer Biospecimen Collection |
NCT05616650 |
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor |
NCT05013255 |
Pioglitazone Therapy Targeting Fatigue in Breast Cancer |
NCT05553522 |
Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer |
NCT03757689 |
Neoadjuvant PD-1 Blockade in Patients With Stage IIB/C Melanoma |
NCT05859971 |
ICG and SLN Mapping |
NCT05812924 |
A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause |
NCT03779867 |
Acute Exercise Intervention in Breast Cancer Survivors |
NCT06219434 |
Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer |
NCT05787834 |
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer |
NCT05132296 |
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer |
NCT06090643 |
Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups |
NCT04267796 |
Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women |
NCT04378751 |
Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer |
NCT05447923 |
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities |
NCT06300463 |
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases |
NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma |
NCT04469764 |
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer |
NCT05896189 |
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors |
NCT05663203 |
A Web-Based Dyadic Intervention for Colorectal Cancer |
NCT04721886 |
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer |
NCT05595499 |
Treatment of Frailty With Fisetin (TROFFi) in Breast Cancer Survivors |
NCT04913064 |
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer |
NCT05325151 |
Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer |
NCT05325632 |
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab |
NCT05928325 |
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment |
NCT04251416 |
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma |
NCT06115486 |
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer |
NCT03945721 |
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients |
NCT01955460 |
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma |
NCT05689021 |
CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations |
NCT06011772 |
EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer |
NCT05036109 |
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease |
NCT04098081 |
1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma |
NCT04720209 |
Taking AIM at Breast Cancer |
NCT05568550 |
Pembro With Radiation With or Without Olaparib |
NCT04375527 |
Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma |
NCT05408260 |
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer |
NCT03719131 |
Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy |
NCT03646617 |
Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma |
NCT04896073 |
Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP) |
NCT04824027 |
Breast Elasticity Imaging During Neoadjuvant Chemotherapy |
NCT04506567 |
Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC |
NCT05200442 |
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer |
NCT06100705 |
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC |
NCT05603910 |
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma |
NCT05830058 |
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma |
NCT05391126 |
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care |
NCT03675893 |
Abemaciclib + Letrozole +/- Metformin in Recurrent or Persistent Endometrial Cancer |
NCT05225428 |
Video Education With Result Dependent dIsclosure |
NCT02600949 |
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer |
NCT03977233 |
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer |
NCT06193486 |
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC |
NCT05841706 |
Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer |
NCT05141149 |
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer |
NCT04777071 |
An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer |
NCT06072807 |
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer |
NCT04674306 |
Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer |
NCT03439735 |
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC |
NCT05882253 |
Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial) |
NCT06028932 |
A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients |
NCT04533763 |
Living WELL: A Web-Based Program for Ovarian Cancer Survivors |
NCT04866810 |
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN) |
NCT06178354 |
Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer |
NCT02681549 |
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer |
NCT02600156 |
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors |
NCT05288777 |
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer |
NCT05733351 |
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer |
NCT06015659 |
ZN-c3 + Gemcitabine in Pancreatic Cancer |
NCT06046040 |
TmPSMA-02 in mCRPC |
NCT05764330 |
Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance |
NCT06006806 |
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy |
NCT06260332 |
Physical Activity Intervention for the Improvement of Pain in Young, Hispanic Breast Cancer Survivors |
NCT05918263 |
Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial |
NCT05524584 |
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer |
NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
NCT05497531 |
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers |
NCT04486755 |
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) |
NCT05150652 |
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer |
NCT05568680 |
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma |
NCT05826964 |
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer |
NCT05168618 |
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial |
NCT02884648 |
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery |
NCT04984343 |
Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer |
NCT05496959 |
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study |
NCT03526432 |
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer |
NCT03729115 |
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer |
NCT02334579 |
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer |
NCT06006299 |
Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC) |
NCT04407611 |
Scalable Communication Modalities for Returning Genetic Research Results |
NCT05660083 |
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) |
NCT04174352 |
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer |
NCT06074510 |
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer |
NCT03833921 |
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer |
NCT05193149 |
Inspiratory Muscle Training in Obese Breast Cancer Survivors |
NCT03955627 |
REJOIN Trial for Older Breast Cancer Survivors |
NCT04978675 |
An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer |
NCT02064673 |
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy |
NCT05998135 |
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer |
NCT06269978 |
Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer |
NCT05154487 |
A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer |
NCT00969111 |
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy |
NCT06028022 |
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors |
NCT06018311 |
Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads |
NCT04903119 |
Nilotinib Plus Dabrafenib/Trametinib in Metastatic Melanoma |
NCT06086704 |
Study of 18F-FFNP Breast PET/MRI |
NCT06258993 |
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation |
NCT03847311 |
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients |
NCT05386719 |
Cardiometabolic Screening Program |
NCT05756166 |
Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer |
NCT04550845 |
Understanding of Genetics by Men at Risk for Prostate Cancer |
NCT03677739 |
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families |
NCT02361320 |
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer |
NCT06055803 |
Heart Health After Cancer Treatment (HEART-ACT) |
NCT05961982 |
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study |
NCT04454528 |
BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy |
NCT06042569 |
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial |
NCT05376878 |
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis |
NCT04263025 |
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft |
NCT03407417 |
A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care |
NCT04493333 |
Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors |
NCT05069038 |
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy |
NCT05679674 |
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer |
NCT04995198 |
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness |
NCT04887805 |
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer |
NCT04203641 |
L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer |
NCT05703178 |
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia |
NCT04365569 |
Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program |
NCT05034627 |
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer |
NCT04975516 |
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer |
NCT04923542 |
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases |
NCT04724499 |
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy |
NCT04265872 |
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC |
NCT04870515 |
Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study |
NCT05444231 |
Breaking Through the Brain Fog: An Online Research Study |
NCT05289193 |
CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma |
NCT04734730 |
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer |
NCT04115163 |
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer |
NCT04998682 |
Prospective Evaluation of Targeted Axillary Dissection (TAD) |
NCT05980182 |
Engaging Black Men in Colorectal Cancer Screening |
NCT05700669 |
Study To Assess Safety And Efficacy Of AsiDNA In Combination With Olaparib In Participants With Recurrent Solid Tumors |
NCT04636710 |
Refining Local-Regional Therapy for IBC |
NCT05869682 |
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy |
NCT05054296 |
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring |
NCT02871726 |
Transrectal Ultrasound Robot-Assisted Prostate Biopsy |
NCT05341349 |
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-100M for the Treatment of Melanoma Brain Metastases |
NCT04116073 |
INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer |
NCT05438563 |
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer |
NCT04753879 |
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. |
NCT06011499 |
Internet-Based Lifestyle Intervention (iLIVE) to Eradicate Obese Frailty in Prostate Cancer Survivors |
NCT05830838 |
Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer |
NCT03716739 |
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency |
NCT04983342 |
Apollo Device for Metastatic Breast Cancer (MBC) |
NCT04215029 |
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans |
NCT05763199 |
Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy |
NCT06145399 |
A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer |
NCT03987217 |
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients |
NCT05582759 |
Sleep Hygiene Education, ReadiWatchTM Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia Effect, on Symptom Relief for Men With Prostate Cancer Receiving Androgen Deprivation Therapy |
NCT05929820 |
Impact of Protect Your Colon™ on CRC Screening |
NCT06128525 |
Prostate Resection After Microwave Ablation (PRAMA) |
NCT03725761 |
Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy |
NCT03856658 |
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases |
NCT01985828 |
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer |
NCT05447910 |
Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer |
NCT04379414 |
YES Study - Newly Diagnosed/Metastatic Intervention |
NCT04668976 |
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma |
NCT05710328 |
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial |
NCT05471414 |
Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer |
NCT02802553 |
Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions |
NCT02476786 |
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score |
NCT04947254 |
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer |
NCT03285412 |
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer |
NCT06069778 |
Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma |
NCT04587128 |
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC |
NCT05694559 |
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics |
NCT06234423 |
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors |
NCT06302595 |
MRI Guided Prostate Biopsy |
NCT06008158 |
Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Patients With Low Risk, Hormone Responsive Breast Cancer |
NCT05505045 |
Metacognitive Strategy Training in Cancer-related Cognitive Impairment |
NCT04722341 |
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators |
NCT05036681 |
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma |
NCT04119024 |
Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma |
NCT05464082 |
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC |
NCT04356729 |
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma |
NCT03772834 |
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer |
NCT05786014 |
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies |
NCT04614194 |
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib |
NCT04955743 |
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma |
NCT05219695 |
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) |
NCT06136923 |
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer |
NCT04973930 |
Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer |
NCT06040125 |
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial |
NCT04088708 |
Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors |
NCT03580499 |
Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy |
NCT04521764 |
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer |
NCT04727632 |
[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial |
NCT05996107 |
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Node Positive, HR+/HER2- Breast Cancer |
NCT03825289 |
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer |
NCT06102902 |
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer |
NCT06039371 |
Supraphysiological Androgen to Enhance Chemotherapy Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study |
NCT05560685 |
SMART-ER: Symptom Monitoring With Patient-reported Outcomes |
NCT03769415 |
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA |
NCT05501704 |
ETHAN - ET for Male BC |
NCT05155046 |
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy |
NCT04731844 |
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer |
NCT05730712 |
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT05502315 |
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer |
NCT06296147 |
Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy |
NCT06085833 |
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions |
NCT05121545 |
Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors |
NCT05678322 |
Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy |
NCT05647564 |
PET/CT Characterization of Treatment Resistance |
NCT05381103 |
PSMA-PET to Guide Prostatectomy |
NCT05746325 |
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast Cancer |
NCT05043012 |
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) |
NCT05038332 |
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT]) |
NCT05336786 |
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount) |
NCT04656678 |
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer |
NCT04394676 |
The Impact of Low Pressure Pneumo in RARP II |
NCT06057636 |
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study |
NCT01984138 |
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy |
NCT04477343 |
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma |
NCT05765500 |
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life |
NCT02290834 |
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer |
NCT04233385 |
Myofascial Massage for Pain and Immobility Following Breast Cancer Surgery |
NCT04648904 |
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer |
NCT02307058 |
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy |
NCT03995082 |
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey |
NCT04030559 |
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects |
NCT05846789 |
Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers |
NCT04389281 |
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma |
NCT05704283 |
3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer |
NCT05340673 |
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer |
NCT04986579 |
Scalp Cooling in MBC |
NCT06185205 |
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy |
NCT04120246 |
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer |
NCT04871139 |
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer |
NCT05452681 |
A QoL Intervention for Young African American Breast Cancer Survivors |
NCT05456373 |
Intraoperative Use of ClearEdge Device in Breast Conserving Surgery |
NCT06153836 |
Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction |
NCT05037500 |
Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer |
NCT03983577 |
Efficacy of Point Of Service Testing in MBC |
NCT06193070 |
An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutrition Information |
NCT05591547 |
Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen for patIents With Favorable Risk breaSt cancEr |
NCT04049214 |
Perioperative Mindfulness Proposal |
NCT02977468 |
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer |
NCT04030507 |
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer |
NCT05990426 |
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy |
NCT03880422 |
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors |
NCT05674578 |
Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors |
NCT05983380 |
The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors |
NCT05114798 |
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers |
NCT03844750 |
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases |
NCT05243056 |
A Quality of Life Intervention (Y-AMBIENT) for Young African American With Stage I-III Breast Cancer |
NCT04692818 |
3D Ultrasound Breast Imaging |
NCT04791384 |
Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer |
NCT05419479 |
Switch Maintenance in Pancreatic |
NCT03366155 |
Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver |
NCT04290897 |
Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors |
NCT04754412 |
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study |
NCT05049746 |
Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy |
NCT05984589 |
Personalized Self-Management Training Compared to Standardized Self-Management Training in Colorectal Cancer Patients. |
NCT04717050 |
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity |
NCT03424850 |
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy |
NCT04849871 |
Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma |
NCT04576871 |
Re-treatment 225Ac-J591 for mCRPC |
NCT03785288 |
Vaginal Cuff Brachytherapy Fractionation Study |
NCT03941756 |
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer |
NCT05388877 |
E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma |
NCT05298605 |
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women |
NCT05095207 |
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer |
NCT05825482 |
Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout® |
NCT04348747 |
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer |
NCT05677802 |
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer |
NCT03824652 |
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy |
NCT04454086 |
Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors |
NCT04445844 |
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study |
NCT05920798 |
A Study of FRaDCs for Ovarian Cancer |
NCT05222932 |
Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1 |
NCT05915351 |
Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC) |
NCT05960578 |
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study |
NCT06176261 |
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs |
NCT03796559 |
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes |
NCT05785780 |
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings |
NCT04890054 |
Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC |
NCT05823402 |
Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study) |
NCT06105918 |
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer |
NCT04205903 |
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer |
NCT04090567 |
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer |
NCT04715958 |
Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure Estimation |
NCT03987386 |
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer |
NCT01174121 |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer |
NCT05319873 |
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer |
NCT05752448 |
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) |
NCT04471974 |
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT02558946 |
Physical Therapy for Men Undergoing Prostatectomy |
NCT04645810 |
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence |
NCT06022887 |
Time-Restricted Eating and Mindfulness-Based Stress Reduction to Reduce the Risk of Early-Onset Colorectal Cancer |
NCT05975736 |
Searching for Masses and Calcifications at the Same Time in Breast Cancer Screening |
NCT04592237 |
Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer |
NCT04673448 |
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer |
NCT05226663 |
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer |
NCT06067503 |
Biomarkers to Detect Endocrine Therapy Resistance |
NCT03554083 |
Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma |
NCT04374747 |
Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer Risk |
NCT05692024 |
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER |
NCT05672316 |
Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy |
NCT03897270 |
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects |
NCT06137248 |
Study to Assess Colonic Microbiota Changes in Response to Energy Drink Consumption |
NCT04013854 |
Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab |
NCT05716542 |
Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial) |
NCT04428905 |
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer |
NCT03216421 |
Intraoperative Radiation Therapy (IORT) in DCIS |
NCT05231122 |
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer |
NCT05020860 |
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer |
NCT05453630 |
Colonoscopy Outreach for Rural Communities Aim 2 |
NCT05417308 |
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer |
NCT04839614 |
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia |
NCT05428007 |
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma |
NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
NCT04843306 |
Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients |
NCT04789486 |
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer |
NCT06050395 |
The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response |
NCT05491226 |
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation |
NCT04484909 |
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer |
NCT06129747 |
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast |
NCT06184867 |
Choices About Genetic Testing And Learning Your Risk With Smart Technology |
NCT04796818 |
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response |
NCT03572283 |
Bethanechol Prior to Pancreatic Surgery |
NCT05080946 |
Using Aspirin to Improve Immunological Features of Ovarian Tumors |
NCT05141513 |
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma |
NCT04017650 |
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer |
NCT05256745 |
RAGE Inhibition to Decrease Therapy Cardiotoxicity in Women With Early Breast Cancer |
NCT03991962 |
Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma |
NCT06237179 |
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk |
NCT03704662 |
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma |
NCT05286814 |
M9241 in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma |
NCT06161506 |
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer |
NCT05200559 |
T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors |
NCT04599218 |
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer |
NCT02451982 |
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas |
NCT04253483 |
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer |
NCT04485767 |
RESIST-ADT (Androgen Deprivation Therapy) |
NCT06124131 |
Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening |
NCT06166758 |
Feasibility Study: Educational Genetic Test Video |
NCT05712668 |
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors |
NCT04683315 |
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples |
NCT04677816 |
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients |
NCT03384836 |
Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery |
NCT05634720 |
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer |
NCT02946697 |
A Culturally Sensitive Social Support Intervention |
NCT03449238 |
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients |
NCT05627635 |
FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer |
NCT05877144 |
Low-Intensity Shockwave Therapy to Treat Erectile Dysfunction and Preserve Erectile Function After Prostate Cancer Surgery |
NCT05683964 |
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression |
NCT05608252 |
VS-6766+Abema+Fulv in Met HR+/HER- BC |
NCT04005690 |
Targeted Pathway Inhibition in Patients With Pancreatic Cancer |
NCT04927663 |
11C-YJH08 PET Imaging for the Detection of Glucocorticoid Receptor Expression in Patients With Metastatic Prostate Cancer |
NCT04940286 |
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer |
NCT06112314 |
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) |
NCT05565534 |
Diabetes Care for Breast Cancer Patients |
NCT03213041 |
Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer |
NCT05610826 |
Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver |
NCT06034197 |
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy |
NCT05535192 |
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients |
NCT05686122 |
Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac) |
NCT06037954 |
A Study of Mental Health Care in People With Cancer |
NCT04705363 |
A Sociolinguistic-enabled Web Application to Develop Precision Health Intervention for African Americans |
NCT04915508 |
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy |
NCT04959474 |
SABR-CaRe in Early Stage Breast Cancer |
NCT05693766 |
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort |
NCT05241249 |
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma |
NCT04313114 |
The PRIME-CRC Trial to Promote CRC Screening in Rural Communities |
NCT03640208 |
Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans |
NCT05557877 |
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer |
NCT04763915 |
Improving Care After Inherited Cancer Testing |
NCT04407247 |
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma |
NCT05365893 |
PHL Treatment in Pancreatic Cancer |
NCT03484299 |
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma |
NCT05055323 |
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer |
NCT03540017 |
HIPEC After Initial CRS in Patients Who Have Received NACT |
NCT05155501 |
Clinical Trial of Approaches to Prostate Cancer Surgery |
NCT02452008 |
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer |
NCT02830724 |
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
NCT04981834 |
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer |
NCT02949284 |
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery |
NCT04646434 |
Brain and Pelvic Floor Muscle Activity of Patients Undergoing Robot-Assisted Radical Prostatectomy |
NCT04946370 |
Phase I/II Trial of Pembrolizumab and Androgen-receptor Pathway Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer |
NCT03073785 |
Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer |
NCT05269160 |
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer and Head and Neck Cancer Patients (TOPAZ) |
NCT04599140 |
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial |
NCT02484404 |
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... |
NCT05366842 |
Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care |
NCT03796273 |
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases |
NCT04305834 |
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. |
NCT04837209 |
Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer |
NCT05515978 |
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients |
NCT05468034 |
Exercise in Metastatic Breast Cancer: EMBody |
NCT06084338 |
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc |
NCT03507608 |
Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression |
NCT04975217 |
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer |
NCT03865875 |
Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program |
NCT05114421 |
Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients |
NCT05684367 |
Exercise to ReGain Stamina and Energy (The EXERGISE Study) |
NCT05289830 |
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer |
NCT06096623 |
The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment |
NCT06220214 |
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer |
NCT04594772 |
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma |
NCT04606914 |
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
NCT06150664 |
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies |
NCT03732950 |
Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer |
NCT06117241 |
Reducing Metabolic Dysregulation in Dyads |
NCT06095089 |
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer |
NCT03851237 |
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy |
NCT05458544 |
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application |
NCT05645471 |
Together After Cancer |
NCT06016725 |
Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial |
NCT02095184 |
GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients |
NCT04965311 |
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy |
NCT05162846 |
Methods for Increasing Genetic Testing Uptake in Michigan |
NCT06188559 |
A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer |
NCT05142358 |
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose |
NCT06242470 |
A Study of MGC026 in Participants With Advanced Solid Tumors |
NCT04563507 |
Combined Immunotherapies in Metastatic ER+ Breast Cancer |
NCT04444622 |
Immunotherapy for Third Line Metastatic Colorectal Cancer |
NCT04751435 |
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients |
NCT04879940 |
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization |
NCT04620603 |
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer |
NCT02757859 |
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery |
NCT06112990 |
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression |
NCT04990609 |
A Single-arm Phase II Study to Evaluate the Safety and Efficacy of Combination Systematic Chemotherapy and Multiple Rounds of Endoscopic Ultrasound-guided Radiofrequency Ablation in Pancreatic Cancer |
NCT03907527 |
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
NCT01794403 |
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer |
NCT04514692 |
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging |
NCT03008408 |
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma |
NCT06119425 |
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands |
NCT05036096 |
Cone Beam Breast CT for Breast Cancer Screening |
NCT03546686 |
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer |
NCT05789433 |
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer |
NCT05296421 |
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer |
NCT01727284 |
MR-Guided Cryoablation of Prostate Bed Recurrences |
NCT03991741 |
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors |
NCT05422794 |
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer |
NCT04443413 |
Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients |
NCT02422641 |
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis |
NCT04234386 |
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer |
NCT05039801 |
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors |
NCT05336266 |
A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma |
NCT05230810 |
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer. |
NCT05455658 |
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
NCT04527900 |
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach |
NCT04906200 |
Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors |
NCT05954143 |
Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer |
NCT05946603 |
IS-002 in Prostate Cancer |
NCT03671044 |
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients |
NCT04862585 |
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel |
NCT05301114 |
Social Risk Factors and Discrimination in Cancer Survivorship |
NCT05868187 |
CanRestoreFunction Cancer-related Fatigue ( CRF ) |
NCT02891538 |
Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients |
NCT04993313 |
Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study |
NCT06058650 |
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities |
NCT02760030 |
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery |
NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
NCT05464810 |
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer |
NCT05040568 |
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD) |
NCT03789097 |
Vaccination With Flt3L, Radiation, and Poly-ICLC |
NCT05698576 |
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer |
NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors |
NCT05412953 |
Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain |
NCT04943536 |
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer |
NCT05047926 |
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients |
NCT05368428 |
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer |
NCT04837833 |
An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma |
NCT01492972 |
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer |
NCT05251714 |
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer |
NCT05677048 |
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention |
NCT04899908 |
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases |
NCT05524428 |
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study |
NCT05271318 |
Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Ovarian Cancer |
NCT04743934 |
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer |
NCT05369000 |
Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer |
NCT05967533 |
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors |
NCT05597878 |
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy |
NCT04009044 |
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast |
NCT06169371 |
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI) |
NCT04946864 |
A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer |
NCT05853848 |
Mammogram Mail- and Phone-based Interventions |
NCT05807074 |
Impact of Topical Tranexamic Acid in Breast Reconstruction |
NCT05774678 |
Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation |
NCT05754749 |
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions |
NCT05744557 |
Vapocoolant Analgesia for Breast Lymphoscintigraphy |
NCT05731791 |
Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation |
NCT02926690 |
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer |
NCT05496829 |
IMPACT Trial: Intervention to iMProve AdherenCe Equitably |
NCT03715959 |
Nipple Aspirate Fluid in Detecting Breast Cancer |
NCT05291507 |
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System |
NCT05206331 |
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study |
NCT05181722 |
Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic |
NCT04331041 |
Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma |
NCT04387227 |
Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
NCT03384238 |
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery |
NCT04534010 |
Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts |
NCT06171607 |
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses |
NCT04348123 |
Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography |
NCT04258280 |
Improving Genetic Counseling for BRCA+ Mothers |
NCT04225572 |
Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) |
NCT04175639 |
mHealth Behavioral Cancer Pain Intervention for Medically Undeserved Patients |
NCT06299163 |
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors |
NCT04704505 |
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) |
NCT03321045 |
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness |
NCT03238976 |
Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy |
NCT06146920 |
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation |
NCT02769962 |
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer |
NCT05637216 |
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients |
NCT05809752 |
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) |
NCT03716193 |
Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry |
NCT03953157 |
Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors |
NCT06161493 |
ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors |
NCT05494697 |
Ampligen Compared to No Treatment Following FOLFIRINOX in Subjects With Locally Advanced Pancreatic Adenocarcinoma |
NCT04771520 |
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors |
NCT06018337 |
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) |
NCT05056844 |
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge |
NCT04762979 |
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer |
NCT06171789 |
PRO1107 in Patients With Advanced Solid Tumors |
NCT04333706 |
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER) |
NCT05960188 |
Project 1: Self-Triage by 2D Full-field Digital Mammography or Synthetic Images |
NCT04282044 |
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies |
NCT04175431 |
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study |
NCT04055649 |
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer |
NCT05733000 |
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors |
NCT06275126 |
Optimizing Surgical Decisions in Young Adults With Breast Cancer |
NCT04815083 |
Fluorescence Imaging of Carcinoma During Breast Conserving Surgery |
NCT05316324 |
A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction |
NCT05223322 |
Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction |
NCT05892068 |
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain |
NCT05195970 |
Walnuts and Colon Health |
NCT05314179 |
Dignity, Legacy, Advocacy, and Support for Advanced Cancer: Reimagined End of Life Care in the Black Community |
NCT05655598 |
TAS-116 Plus Palbociclib in Breast and Rb-null Cancer |
NCT06051942 |
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs |
NCT04692831 |
Testing a New Imaging Agent to Identify Cancer |